BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10360539)

  • 1. The impact of edema on planning 125I and 103Pd prostate implants.
    Yue N; Dicker AP; Nath R; Waterman FM
    Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
    Yue N; Chen Z; Nath R
    Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
    Chen Z; Deng J; Roberts K; Nath R
    Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema.
    Monajemi TT; Clements CM; Sloboda RS
    Med Phys; 2011 Apr; 38(4):2289-98. PubMed ID: 21626964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
    Nath R; Meigooni AS; Melillo A
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
    Waterman FM; Yue N; Corn BW; Dicker AP
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1069-77. PubMed ID: 9719117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
    Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
    Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
    Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
    Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
    Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of post-implant edema on the rectal dose in prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):571-6. PubMed ID: 10524408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostatic edema on CT-based postimplant dosimetry.
    Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
    Villeneuve M; Leclerc G; Lessard E; Pouliot J; Beaulieu L
    Med Phys; 2008 May; 35(5):1970-7. PubMed ID: 18561673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seed fixity in the prostate/periprostatic region following brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.